BioAge Labs, Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 13 | Q2 13 | Q3 13 | Q4 13 | Q1 14 | Q2 14 | Q3 14 | Q4 14 | Q1 15 | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +211.0% | -15.7% | -49.3% | -20.2% | +18.2% | +13.2% | -34.3% | +19.1% | -6.9% | +2.9% | +215.9% | +31.3% | +72.9% | +45.2% | -82.8% | +236.3% | +94.1% | -19.9% | +63.5% | -100.0% | – | – | – | – | – | – | – | – | +66.2% | -14.8% | +49.9% | -9.9% | -11.6% | – | |
| – | +610.9% | -53.6% | -35.3% | -34.0% | +704.4% | -35.7% | +42.6% | -85.0% | +142.6% | -51.2% | +222.6% | +158.8% | +13.7% | +44.6% | -58.5% | +96.8% | +39.4% | +4.3% | +8.7% | – | – | – | – | – | – | – | – | – | – | – | – | -8.7% | – | – | |
| – | -389.6% | – | -92.7% | +357.0% | -2,693.9% | – | – | – | -818.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +66.2% | -14.8% | +49.9% | -12.0% | -9.5% | – | |
| – | -30.8% | -34.6% | +26.8% | -5.3% | +28.5% | -16.0% | +11.9% | +15.1% | +7.6% | +21.0% | -21.4% | -60.8% | -17.7% | +16.5% | +15.6% | -24.3% | -0.2% | -23.4% | -0.8% | +582.2% | +14.9% | -29.3% | +54.3% | -7.5% | +12.3% | +91.2% | -4.0% | -42.2% | +78.6% | -6.7% | +32.3% | -16.7% | +19.4% | – | |
| – | -48.5% | +91.1% | +57.2% | -5.9% | -37.6% | +30.0% | +20.8% | -16.7% | +24.7% | -29.3% | +52.2% | -25.8% | +63.7% | -46.4% | +7.6% | +207.2% | -44.9% | -20.6% | +4.4% | +78.2% | +20.5% | -19.7% | +4.7% | -0.6% | +37.4% | -1.4% | +29.7% | +10.6% | +8.1% | -9.0% | +4.8% | +10.5% | -4.1% | – | |
| – | +73.3% | -65.0% | +29.1% | -3.2% | +14.0% | -16.4% | +0.9% | +17.0% | +23.1% | -5.8% | -6.7% | -25.1% | -7.9% | -18.2% | +11.1% | +49.5% | -28.3% | -12.8% | +1,426.7% | -86.0% | +16.6% | -26.3% | +37.5% | -5.8% | +19.2% | +62.1% | +2.5% | -29.4% | +51.9% | -7.3% | +25.0% | -10.8% | +13.2% | – | |
| – | – | +46.4% | -0.5% | +122.8% | -29.1% | -40.2% | -44.2% | -279.6% | – | -64.0% | +3.7% | -195.9% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -75.3% | -51.5% | +776.6% | +0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +157.1% | +17.9% | +6.5% | -52.4% | -63.6% | -12.4% | -17.8% | -20.1% | -21.2% | -25.9% | -38.3% | -57.6% | -97.4% | – | |
| – | – | +46.4% | -0.5% | +122.8% | -29.1% | -40.2% | -44.2% | -289.7% | – | -64.0% | +3.7% | -241.2% | – | -328.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -52.4% | +53.4% | -25.8% | -62.6% | +91.2% | +25.4% | +47.2% | -331.8% | – | -132.2% | – | +104.4% | -1,290.8% | – | +64.5% | +388.6% | -136.2% | – | +2,337.4% | +157.1% | – | – | – | -63.6% | – | – | – | – | – | – | – | – | – | |
| – | – | +47.2% | +1.7% | +118.9% | -29.1% | -40.1% | -44.1% | -274.4% | – | -64.2% | +3.9% | -223.6% | – | -228.0% | – | – | -6,845.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -11.2% | +202.7% | -93.6% | +320.4% | -40.6% | -246.6% | – | -62.6% | +16.4% | -181.0% | – | -152.6% | – | – | -368.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.